Peter Mahler, MD, PhD headshot

Peter Mahler, MD, PhD

Clinical Professor - Radiation Oncology

Department of Human Oncology

I am a clinical professor in the Department of Human Oncology. In addition to general radiation oncology, I have a strong interest in palliative care. Approximately one half of all radiation oncology patients are treated with palliative intent. A significant fraction of those treated with curative intent develop recurrence months to years after their initial therapy and become palliative patients. Therefore, it is incumbent upon radiation oncologists to have well-honed palliative care skills in order to best serve their patients. I participate in inpatient care with the palliative care team at the University of Wisconsin Hospitals and Clinics. This provides residents the opportunity for additional exposure to and training in palliative care.

I also have an interest in normal tissue damage from radiation because it is the dose-limiting factor in radiation therapy. We are in the process of developing an animal model of normal tissue damage to better understand the basic biology of damage progression, which could aid the development of drugs and techniques to minimize the damage.

Education

Resident, University of Wisconsin–Madison, Radiation Oncology (1991)

Intern, University of Wisconsin–Madison, Radiation Oncology (1988)

MD, University of Washington, Medicine (1987)

Postdoctoral Fellow, University of Wisconsin–Madison, (1981)

PhD, University of Rochester, Radiation Biology (1979)

MS, University of Illinois, Physics (1971)

BS, Valparaiso University, Physics (1970)

Academic Appointments

Clinical Professor, Human Oncology (2010)

Assistant Professor, Human Oncology (1994)

Selected Honors and Awards

Clinical Oncology Fellowship, American Cancer Society (1990–1991)

Research Focus

Palliative Care, Normal Tissue Damage from Radiation Therapy


Dr. Peter Mahler is a radiation oncologist with a strong interest in palliative care. He participates in inpatient care with the palliative care team. He also has an interest in the basic biology of damage progression of normal tissue from radiation.